300529.SZ
健帆生物
SZSE · Healthcare · C 制造业 · CN
CNY 15.56
−1.27%Margins
Gross margin
77.7%
EBITDA margin
40.7%
EBIT margin
35.3%
Net margin
27.9%
FCF margin
26.9%
15.3%
Return on equity
10.2%
Return on assets
18.5%
Return on invested capital
0.37x
Asset turnover
CNY 708.1M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026